Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer.
Boccardo F, Rubagotti A, Conti G, Potenzoni D, Manganelli A, Del Monaco D. Boccardo F, et al. Among authors: rubagotti a. Cancer Chemother Pharmacol. 2005 Oct;56(4):415-20. doi: 10.1007/s00280-005-1016-1. Epub 2005 Apr 19. Cancer Chemother Pharmacol. 2005. PMID: 15838655 Clinical Trial.
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial.
Boccardo F, Rubagotti A, Puntoni M, Guglielmini P, Amoroso D, Fini A, Paladini G, Mesiti M, Romeo D, Rinaldini M, Scali S, Porpiglia M, Benedetto C, Restuccia N, Buzzi F, Franchi R, Massidda B, Distante V, Amadori D, Sismondi P. Boccardo F, et al. Among authors: rubagotti a. J Clin Oncol. 2005 Aug 1;23(22):5138-47. doi: 10.1200/JCO.2005.04.120. Epub 2005 Jul 11. J Clin Oncol. 2005. PMID: 16009955 Clinical Trial.
Switching to aromatase inhibitors in early breast cancer.
Boccardo F, Rubagotti A. Boccardo F, et al. Among authors: rubagotti a. Lancet. 2007 Feb 17;369(9561):533-5. doi: 10.1016/S0140-6736(07)60201-3. Lancet. 2007. PMID: 17307082 No abstract available.
Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen receptor-positive breast cancer patients. Very late results of the 'gruppo di ricerca per la chemio-ormonoterapia adiuvante (GROCTA)' 01-Trial in early breast cancer.
Boccardo F, Guglielmini P, Parodi A, Rubagotti A. Boccardo F, et al. Among authors: rubagotti a. Breast Cancer Res Treat. 2011 Apr;126(3):653-61. doi: 10.1007/s10549-011-1405-6. Epub 2011 Feb 24. Breast Cancer Res Treat. 2011. PMID: 21347647 Clinical Trial.
Italian Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group Trials. GROCTA Trials.
Boccardo F, Rubagotti A, Amoroso D, Mesiti M, Pacini P, Gallo L, Sismondi P, Giai M, Genta F, Mustacchi G, Agostara B, Bolognesi A, Villa E, Schieppati G, Ausili Cefaro GP, Bellantone R, Farris A, Sassi M, Patrone F. Boccardo F, et al. Among authors: rubagotti a. Recent Results Cancer Res. 1998;152:453-70. doi: 10.1007/978-3-642-45769-2_44. Recent Results Cancer Res. 1998. PMID: 9928580 Review.
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial.
Boccardo F, Rubagotti A, Guglielmini P, Fini A, Paladini G, Mesiti M, Rinaldini M, Scali S, Porpiglia M, Benedetto C, Restuccia N, Buzzi F, Franchi R, Massidda B, Distante V, Amadori D, Sismondi P. Boccardo F, et al. Among authors: rubagotti a. Ann Oncol. 2006 Jun;17 Suppl 7:vii10-4. doi: 10.1093/annonc/mdl941. Ann Oncol. 2006. PMID: 16760270 Free article. Clinical Trial.
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: long term results of the Italian Tamoxifen Anastrozole trial.
Boccardo F, Guglielmini P, Bordonaro R, Fini A, Massidda B, Porpiglia M, Roagna R, Serra P, Orzalesi L, Ucci G, Rubagotti A. Boccardo F, et al. Among authors: rubagotti a. Eur J Cancer. 2013 May;49(7):1546-54. doi: 10.1016/j.ejca.2012.12.025. Epub 2013 Feb 14. Eur J Cancer. 2013. PMID: 23415888 Clinical Trial.
121 results